We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
German pharmacists' federation BVAV has claimed that new payment rules are reducing margins on prescription drugs, and may seek compensation for members.
According to a survey conducted by the China Healthcare Association (CHCA), 26% of health supplements sold in retail outlets are bogus or wrongly indicated.
FASgen has been awarded a $500,000 grant from the U.S. National Institutes of Health for completion of the final preclinical safety and animal efficacy work in support of the investigational new drug application for FAS20013 in MDR-TB.
Norwood Abbey announced that a further patent relating to its immunology technology has been granted in Australia, further strengthening Norwood's intellectual property position in the immunology area.
Diatos S.A., a Paris-based privately held biopharmaceutical company, and Servier, France's largest privately owned pharmaceutical company, announced a research collaboration involving FTE support and a license option to apply the Diatos Vectocell technology to Servier's oncology research program in order to enhance the efficacy and safety of a Servier small molecule drug candidate.
Leading French pharmaceutical company Fournier Pharma and ComGenex have announced
a long-term collaboration for the provision of exclusive chemistry services.
A recent ban on the importation of 17 leading drug products, imposed
by Nigerian regulator NAFDAC, has provoked condemnation from the local retail
sector.
The US FDA has issued a stark warning that Mexican counterfeiters are targeting
pharmacies close to the US border, threatening the treatment of vulnerable US
visitors.